BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16354679)

  • 1. Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.
    Kumar RN; Ha JH; Radhakrishnan R; Dhanasekaran DN
    Mol Cell Biol; 2006 Jan; 26(1):50-62. PubMed ID: 16354679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3.
    Kumar RN; Shore SK; Dhanasekaran N
    Oncogene; 2006 Feb; 25(6):899-906. PubMed ID: 16247467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway.
    Dermott JM; Reddy MR; Onesime D; Reddy EP; Dhanasekaran N
    Oncogene; 1999 Dec; 18(51):7185-9. PubMed ID: 10602471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation-specific genes activated by Galpha(12): a role for PDGFRalpha and JAK3 in Galpha(12)-mediated cell proliferation.
    Kumar RN; Radhika V; Audigé V; Rane SG; Dhanasekaran N
    Cell Biochem Biophys; 2004; 41(1):63-73. PubMed ID: 18038259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gα12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation.
    Jung HS; Seo YR; Yang YM; Koo JH; An J; Lee SJ; Kim KM; Kim SG
    Cell Signal; 2014 Jul; 26(7):1456-65. PubMed ID: 24631529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice.
    Lu H; Zhang C; Song N; Lu C; Tong L; Huang X; Kim YC; Chen J; Xu W
    Cell Physiol Biochem; 2017; 43(1):158-171. PubMed ID: 28848093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of PAR2 in platelet-derived growth factor receptor-α-positive cell proliferation in the colon of diabetic mice.
    Li YJ; Ao JP; Huang X; Lu HL; Fu HY; Song NN; Xu WX; Chen J
    Physiol Rep; 2021 Nov; 9(21):e15099. PubMed ID: 34755491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Galpha12 and Galpha13 as novel switches for the activity of Nrf2, a key antioxidative transcription factor.
    Cho MK; Kim WD; Ki SH; Hwang JI; Choi S; Lee CH; Kim SG
    Mol Cell Biol; 2007 Sep; 27(17):6195-208. PubMed ID: 17591699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation.
    Madarampalli B; Watts GFM; Panipinto PM; Nguygen HN; Brenner MB; Noss EH
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1516-1524. PubMed ID: 30876808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α.
    Feng H; Li Y; Yin Y; Zhang W; Hou Y; Zhang L; Li Z; Xie B; Gao WQ; Sarkaria JN; Raizer JJ; James CD; Parsa AT; Hu B; Cheng SY
    Neuro Oncol; 2015 Jun; 17(6):832-42. PubMed ID: 25468898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Src-dependent transactivation of PDGFR contributes to TNF-α-induced MMP-9 expression and functional impairment in osteoblasts.
    Tsai CL; Chen WC; Lee IT; Chi PL; Cheng SE; Yang CM
    Bone; 2014 Mar; 60():186-97. PubMed ID: 24361597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
    Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
    Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.
    Noël LA; Arts FA; Montano-Almendras CP; Cox L; Gielen O; Toffalini F; Marbehant CY; Cools J; Demoulin JB
    Mol Oncol; 2014 May; 8(3):728-40. PubMed ID: 24618081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G2A is an oncogenic G protein-coupled receptor.
    Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
    Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CrkII induces serum response factor activation and cellular transformation through its function in Rho activation.
    Iwahara T; Akagi T; Shishido T; Hanafusa H
    Oncogene; 2003 Sep; 22(38):5946-57. PubMed ID: 12955073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of matrix metalloproteinases and invasion by G(alpha12/13) proteins in NIH3T3 mouse fibroblast cells.
    Kim ES; Lee KM; Noh DY; Moon A
    Oncol Res; 2011; 19(6):297-301. PubMed ID: 21776825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
    Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.
    Zhang H; Bajraszewski N; Wu E; Wang H; Moseman AP; Dabora SL; Griffin JD; Kwiatkowski DJ
    J Clin Invest; 2007 Mar; 117(3):730-8. PubMed ID: 17290308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gα
    Yoo EJ; Cao G; Koziol-White CJ; Ojiaku CA; Sunder K; Jude JA; Michael JV; Lam H; Pushkarsky I; Damoiseaux R; Di Carlo D; Ahn K; An SS; Penn RB; Panettieri RA
    Br J Pharmacol; 2017 Dec; 174(23):4383-4395. PubMed ID: 28921504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.